- Benzinga•last month
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday January 25, 2017. EU clears Abbott Acquisition of Alere Subject to Divestments The Approval : Alere Inc (NYSE: ...
- PR Newswire•last month
WALTHAM, Mass., Jan. 25, 2017 /PRNewswire/ -- Alere Inc. (ALR), a global leader in rapid diagnostics, announced that the European Commission has granted clearance for Abbott Laboratories (ABT) to acquire Alere Inc. "This regulatory clearance marks a significant milestone toward the completion of our transaction with Abbott and we remain highly confident that the merger will close according to the terms of the agreement," said Namal Nawana, CEO and President of Alere. As previously announced on February 1, 2016, Alere has entered into a definitive agreement under which Abbott will acquire Alere for $56 per common share in cash.
- Reuters•last month
European Union antitrust regulators cleared Abbott Laboratories' proposed $5.8 billion acquisition of diagnostic test maker Alere on Wednesday, subject to the divestment of some of Alere's operations. The European Commission, which is in charge of competition policy in the European Union, said there were overlaps in analysers used in testing of blood gases and cardiac markers.
ALR : Summary for Alere Inc. - Yahoo Finance
Alere Inc. (ALR)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||39.93 - 40.37|
|52 Week Range||31.47 - 53.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-56.99|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|